Imaging Findings
US (Fig 1) revealed a heterogeneous complex mass that contained cystic and solid areas in the epigastric area. CT revealed an 11.6 ϫ 11.5-cm well-circumscribed mass (Fig 2a) that was localized to the uncinate process of the pancreas and displaced but did not invade the adjacent viscera, namely, the right kidney. After intravenous injection of contrast media (Figs 2b-2d), heterogeneous enhancement of the mass was seen. This enhancement revealed a peripheral enhancing thick rim that surrounded a central nonenhancing low-attenuation area. At a slightly higher level, the main pancreatic duct was markedly dilated distally (Fig 2b) and displayed discrete intraluminal solid enhancing nodules (Fig 2c) . The adjacent pancreatic tissue appeared slightly atrophic (Fig 2b) . There was no intra-or extrahepatic bile duct dilatation, nor were there any extrapancreatic signs of malignancy. No abnormalities were seen in the rest of the abdomen. Surgery was performed with a Whipple procedure. Pathologic examination of the surgical specimen revealed a yellowish solid tumor (Fig 3) . Histologic analysis revealed the papillary component of this huge intraductal papillary mucinous tumor (IPMT) of the pancreas.
Discussion
IPMT of the pancreas is a pancreatic cystic neoplasm, and it represents about 1%-2% of pancreatic exocrine tu- mors (1) . IPMTs occur with equal frequency in male and female subjects, and the peak time of occurrence is the 6th decade of life, regardless of sex (2) . Approximately 75% of IPMTs originate from the main pancreatic duct within the head of the pancreas (3). Imaging of IPMTs is important not only to identify the tumor but also to determine the appropriate treatment strategy in relation to the site and size of the lesion (2) . Although the presence of a dominant mass of considerable size (as in the present case) is a rare occurrence, it should not preclude the diagnosis of IPMT.
Imaging findings vary according to the ductal involvement of the disease, which can be divided into three types: (a) the main duct type, (b) the branch duct type, and (c) the combined type (4) . In main duct IPMTs, the lesion is usually homogeneous and hypoechoic on US images and hypoattenuating on CT images. Intraductal filling defects can be seen in the main duct. These defects represent mucin globules, papillary projections of the tumor that are hyperechoic on US images, or both (2, 5) . At CT, unenhanced mucin deposits can be distinguished from contrastenhanced papillary proliferations (5). Sometimes, it is possible to identify amorphous intraductal calcifications, which are thought to represent calcium deposits within the mucinous collections and which may lead to an incorrect diagnosis of chronic pancreatitis (6). Although Fukushima et al (7) reported 5.0 -10.5-cm-diameter IPMTs, large size is an uncommon feature of this tumor.
Branch duct IPMTs, which more frequently are located in the uncinate process, may have a macrocystic or microcystic pattern. The microcystic pattern is characterized by multiple thin septa separating fluid-filled spaces showing US, CT, and magnetic resonance cholangiopancreatography (MRCP) features, such as clustered small cysts with a lobulated contour (2,4). The macrocystic pattern, which is seen more frequently, is characterized by a unilocular or multilocular internal architecture (2) . If the tumor is limited to one of the branch ducts, it has a unilocular cystic appearance (4). In later stages, the main duct may also be dilated because of mucin accumulation (2), and severe pancreatic atrophy may follow (4). Demonstration of communication between the lesion and the main duct leads to the correct diagnosis and can occasionally be shown by using thin-section spiral CT (2) .
In the combined type of IPMT, both the branch ducts and the main pancreatic duct are involved (4). The duodenal papilla may protrude into the duodenal lumen (4). This finding, which is more frequent in malignant forms (4), is virtually pathognomonic of IPMT (2) .
Endoscopically, the ampulla of Vater is often prominent, giving rise to an abundant discharge of mucinous fluid (8). Endoscopic retrograde cholangiopancreatography (ERCP) may be the In a, an 11.6 ϫ 11.5-cm well-circumscribed mass ‫)ء(‬ localized at the pancreatic head can be seen. The right kidney (arrowhead) is also visible. In b, the main pancreatic duct ‫)ء(‬ is slightly dilated, and the adjacent pancreatic tissue (arrowhead) appears slightly atrophic. In c, a mass with a peripheral enhancing thick rim surrounding a central low-attenuation area is visible. A nodule (arrowhead) can also be seen. In d, there are some discrete intraluminal solid enhancing nodules (arrow). 
DIAGNOSIS PLEASE: Intraductal Papillary Mucinous Tumor (Main Duct Type) of the Pancreas
Ferreira et al most direct method with which to diagnose IPMT when it shows the characteristic appearance of mucin discharge from a protruded papilla of Vater (9), the dilated pancreatic duct with intraluminal filling defects due to the presence of mucous plugs (10), and the direct communication of the cystically dilated ductal segment with the main pancreatic duct (2) . The dilated duct may lead to a grapelike cluster of cysts with pooling of contrast material, or it may be obstructed by the mucin or the hyperplastic papillary epithelium (10). Sometimes, it demonstrates a fistulous tract leaking mucin between the lesion and the duodenal wall (6). The ERCP data are not constant because mucous plugs may occlude the patency of the ampullary orifice, obviating retrograde opacification by the contrast material (6). MRCP is more sensitive than ERCP in the detection of cystic dilatation of the side branches (11), and it enables one to avoid the complications associated with ERCP (9). Nevertheless, inspection of a patulous papilla is only possible with use of ERCP (9), as it is superior to MRCP for depicting direct communication of the lesion with the main pancreatic duct (2). Perhaps secretin-enhanced MRCP may have an added value in this regard (2) .
Despite its unusually large size, IPMT was a likely diagnosis because it appeared as a cystlike tumor of the pancreatic head in a middle-aged man, with CT features of main duct dilatation containing solid papillary projections. The findings in this patient suggest several diagnoses for a cystic pancreatic mass: (a) mucinous cystic neoplasm, (b) serous cystadenoma, (c) solid and papillary epithelial neoplasm, and (d) nonfunctioning islet cell tumor.
Mucinous cystic neoplasms of the pancreas occur in middle-aged women, and the majority of these lesions are located in the pancreatic body or tail (12) . They tend to be large; indeed, many are larger than 10 cm (13) . They can manifest in the form of abdominal pain, a palpable mass, dyspepsia, anorexia, weight loss, nausea, or vomiting. Symptoms usually result from compression or displacement of neighboring organs and are commonly insidious and of long duration. When symptoms are located in the pancreatic head, they cause early jaundice, which is commonly seen in malignant neoplasms (12) . Pathologically, mucinous cystic tumors are encapsulated and multiloculated, with fewer than six cysts being larger than 2 cm in diameter (14) . The cystic walls are often thickened, and irregular septa or papillary projections may be seen (14) . The amount of stroma varies and, when small, the septa may not be apparent (15) . Contrary to IPMTs, mucinous cystic tumors tend to occur in female patients and are generally located in the body or tail of the pancreas, without accompanying ductal dilatation.
In 1978, Compagno and Oertel (16) differentiated serous cystadenoma from mucinous cystic tumor. Serous cystadenomas are almost always benign; malignant forms are exceedingly rare. Benign serous cystadenomas occur predominantly in elderly women without predilection for a particular segment of the pancreatic gland. Benign serous cystadenomas are often an incidental finding or are seen in patients who present with nonspecific clinical features. The median size of these lesions ranges from a few millimeters to many centimeters. The macroscopic structure of these lesions is greatly variable. Although these lesions are characteristically microlacunar, tumors with a mixed structure consisting of a microlacunar core surrounded by cysts larger than 2 cm in diameter, as well as macrolacunar tumors with unilocular cysts usually larger than 2 cm in diameter, have been reported (10). The preponderance of lesions in women, the central calcification, and the microcystic appearance enable one to readily distinguish this entity from IPMT.
A solid and papillary neoplasm is an uncommon low-grade malignancy that occurs predominantly in young women (mean age, 25 years). These tumors are typically large and encapsulated, have a mean size of 9 cm, and are most commonly located in the tail of the pancreas. The internal architecture shows variable proportions of solid and cystic areas, indicating cystic degeneration and necrosis (17, 18) . Some cases can be exclusively solid, whereas others may be entirely cystic (18) . This entity could be ruled out not only because of the tumor location but also because this patient was a 57-year-old man.
Nonfunctioning islet cell tumors should also be included in the differential diagnosis because they are clinically silent until they are large or until they metastasize, and they may grow to be large (3-24 cm in diameter), with cystic change and necrosis (19) . However, contrary to IPMTs, nonfunctioning islet cell tumors do not have ductal dilatation and internal enhancing papillary projections as imaging features. First address included, add $32 for each additional shipping address $_________
